Regeneron · 3 months ago
Vice President, Research (Neuroscience)
TARRYTOWN
Full-time
Onsite
Director/Executive
$300K/yr - $500K/yr
10+ years expRegeneron Pharmaceuticals is seeking an experienced leader to direct their Neuroscience research team, which focuses on developing therapeutics for neurodegenerative diseases and related disorders. The Vice President of Neuroscience Research will supervise the senior leadership team, set strategic vision, and mentor group members while participating in cross-functional activities and representing the Neuroscience vision to senior leadership and collaborators.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Directly supervise Regeneron’s senior Neuroscience leadership team and manage the broader group, providing vision, inspiration, and both short-term and long-term goals. Communicate priorities, policies, and goals of Regeneron Senior Leadership to the broader Neuroscience group
Identify new strategies or technologies, including genetic medicines, for pursuing novel targets and approaches
Set priorities and ensure progression of, or go/no-go decisions for, targets and projects. Be familiar with processes and procedures for moving targets from preclinical research through the development pipeline
Actively participate in departmental, cross-functional, senior leadership, and external meetings to contribute neuroscience expertise and to represent the goals and vision of the Neuroscience group
Interact broadly and collaboratively with other therapeutic focus areas and technology groups within the company, forging relationships and active collaborations, as well as leveraging technologies to advance neuroscience research as a systems-level endeavor
Identify and mentor the Neuroscience group, providing opportunities, visibility, and challenge in order to develop all group members to their maximum scientific and professional potential
Conduct or oversee review of neuroscience-related documents, including regulatory submissions, manuscripts, contracts, etc
Qualification
Required
Both deep and broad expertise in the field of Neuroscience essential
Familiarity with cutting edge technology, including genetics medicines, and proven experience applying technology to neuroscience-related questions essential
Strong written and oral communication skills with the ability to communicate both science and vision essential
Strong leadership skills with managerial and mentorship experience and excellence essential
Experience with administratively directing a group (managing budget and organization, etc.) essential
At least 10 years experience after PhD; 20+ years desirable; a minimum of 5 years in an industry or translational setting
Preferred
Exposure to drug development or similar regulated activities highly desirable
Broad network of colleagues and collaborators, strong publication record, and national/international reputation desirable
Benefits
Health and wellness programs
Fitness centers
Equity awards
Annual bonuses
Paid time off for eligible employees at all levels
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
10001+ employees
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
Recent News
Pharmaceutical Technology
2026-01-16
2026-01-16
Company data provided by crunchbase